antibodies
Patenting Antibody and Cell Therapies – What to Do and What Not to Do
By Joanna Applequist, Louise Jonshammar, Niklas Mattsson | Posted on September 28, 2020
Antibody drugs and cell therapies are at the heart of new biotechnology science. Not only do they show great promise when it comes to curing disease and helping patients, but also in creating value and growth. Biotech companies need to protect their scientific results and the corresponding investments with strong and durable patents. This is...
Tags: antibodies, Biotechnology, cell therapies, EPO, Litigation, patents
Antibodies vs. the EPO – What scope of protection?
By AWA | Posted on May 21, 2018
Antibodies are currently enjoying great attention and are, together with their derivations and combined applications, growing to occupy centre position in the therapeutics and diagnostics fields. Indeed, the possible industrial applications have increased many fold since the harvesting of the first monoclonal antibodies by researchers Ehrlich & Metchnikoff, which led to an effective syphilis treatment...
Tags: AIS, antibodies, EPO, US
Recent contributors
Partner, European Patent Attorney
Senior Associate, Attorney at Law
Partner, Attorney at Law, Group Vice President
Partner, Attorney at Law, Business Area Manager
Senior Counsel, European Patent Attorney
